COVID-19 booster exemption for severe dyshidrotic eczema.

Bentivegna, Kathryn; Rothe, Marti J; Grant-Kels, Jane M

Bentivegna, Kathryn; Rothe, Marti J; Grant-Kels, Jane M.

Bentivegna K; University of Connecticut School of Medicine, Farmington, Connecticut.
Rothe MJ; Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut.
Grant-Kels JM; Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut; Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida. Electronic address: grant@uchc.edu.

J Am Acad Dermatol ; 2022 Jun 25.

Article in English | MEDLINE | ID: covidwho-1907219

Keywords

COVID-19 booster; atopic dermatitis; dyshidrosis; eczema flare; ethics; informed consent; vaccination exemption

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Year: 2022 Document Type: Article